Skip to main content
. 2010 Jan;69(1):51–57. doi: 10.1111/j.1365-2125.2009.03546.x

Figure 3.

Figure 3

Mean (SD) raltegravir plasma concentration (ng ml−1) vs. time (h) profiles on day 3 (raltegravir) and day 14 (maraviroc + raltegravir). Raltegravir (n = 17) (–•–); Maraviroc + Raltegravir (n = 17) (–○–)